Investigator-Initiated Studies

Advancing science through investigator-led research

Kyowa Kirin investigator-initiated studies

Our commitment

As part of our commitment to delivering innovative therapies to patients worldwide, Kyowa Kirin believes in the need to support independent research conducted by qualified independent investigators.

The scientific evidence generated through these independent research initiatives helps deepen our understanding of the benefit/risk profiles of our products, as well as allows us to explore new opportunities to address unmet medical needs in our therapeutic areas of interest.

Aim of IIS research

At Kyowa Kirin, our goal is to fund independent research that has the potential to produce therapeutic breakthroughs for patients. An IIS may be a clinical or non-clinical study for which the study sponsor requests Kyowa Kirin to provide funding, study drug, or both.

Types of eligible research

We welcome research proposals in our areas of strategic interest listed below. Well-thought-out studies that enhance our delivery of innovative therapies to patients worldwide and improve patient care will be considered.

Central Nervous System

  • Parkinson's Disease


  • Mycosis Fungoides
  • Sézary Syndrome

Rare Disease

  • X-linked Hypophosphatemia
  • Tumor-Induced Osteomalacia

Proposals are evaluated based on scientific merit, as well as alignment with our areas of strategic interest and availability of resources. The study sponsor assumes sole responsibility for study conduct and management, as well as all legal and regulatory requirements.

How to apply

IIS applications are accepted on a rolling submission basis and must include the following:

  • Completed IIS Proposal Form
  • Principal Investigator’s CV

Apply to participate in Kyowa Kirin's investigator-initiated studies program

Please submit these files to:

After you apply

Following review of the initial submission, a full protocol and final study budget will be requested for further evaluation. Applicants will be updated on the status of their proposal throughout the review process. For approved protocol submissions, a written agreement, and Institutional Review Board (IRB) approval is required prior to provision of support.

For questions on any steps of the process, or if you wish to discuss your study concept, 

please reach out to us at:

Fraud Alert

Contact Us


Contact Form

  • For questions related to our products, please use the links provided under Our Medicines.

By clicking the Send button, you authorize Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents to contact you by mail and/or email to provide information on products, programs, services, and disease-state information and/or utilize your information for market research or analytics. Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute your personal information outside the above terms of consent.

Are you visiting this site from Canada? If so, consider visiting our Canadian site. It's designed to bring you up-to-date content.


Click "Leave Page" to visit the Kyowa Kirin Canada site.

Or click “OK” to stay on the Kyowa Kirin US site.

Option to close the window